Institutional Fund
Acuta Capital Partners, LLC
Redwood City, CACIK 15828445 filings on record
Portfolio Value
$140.59M
Q1 2026
Holdings
26
Reported positions
New Buys
5
Opened this quarter
QoQ Change
-4.5%
from $147.29M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Praxis Precision Medicines I19.5%
- Terns Pharmaceuticals Inc18.6%
- Whitehawk Therapeutics Inc8.4%
- Tango Therapeutics Inc6.6%
- Bright Minds Biosciences Inc5.8%
- Sutro Biopharma Inc4.8%
- Other36.4%
Portfolio Holdings
26 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Praxis Precision Medicines I | 84.9K | $27.35M | 19.5% | +1.9K | Added |
| 2 | Terns Pharmaceuticals Inc | 495.8K | $26.14M | 18.6% | −141.3K | Reduced |
| 3 | Whitehawk Therapeutics Inc | 3.41M | $11.77M | 8.4% | 0 | Held |
| 4 | Tango Therapeutics Inc | 441.8K | $9.24M | 6.6% | +159.1K | Added |
| 5 | Bright Minds Biosciences Inc | 112.0K | $8.17M | 5.8% | +27.5K | Added |
| 6 | Sutro Biopharma Inc | 269.4K | $6.71M | 4.8% | +202.0K | Added |
| 7 | Erasca Inc | 354.6K | $5.74M | 4.1% | +354.6K | New |
| 8 | Surrozen Inc | 172.8K | $5.04M | 3.6% | −5.6K | Reduced |
| 9 | Ocular Therapeutix Inc | 592.1K | $5.02M | 3.6% | −460.9K | Reduced |
| 10 | Compass Therapeutics Inc | 849.1K | $4.49M | 3.2% | −244.2K | Reduced |
16 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio